In2Sight | First review meeting

April 29, 2022

The In2Sight Consortium held yesterday the First Review Meeting with experts from the European Innovation Council and SMEs Executive Agency (EISMEA), to follow-up on the project progress from the first year and to hear valuable recommendations from the experts.

The goal of the project is to foster an unprecedented breakthrough in in-vivo optical imaging that will radically renew the biocompatibility tests of biomaterials.

The project is progressing and the first interesting results are starting to be published. Stay tuned for the next updates!

Check the project website for further information about In2Sight:

https://www.in2sight.eu/

You can also contact us at: info@asphalion.com

 

Search News & Events

  • Filter by category

Share

Related news and events

The METHYLOMIC project has been kicked off!

The efficiency and cost-effectiveness will also be assessed in great detail, and experts will guide regulatory approval to ensure delivery of the first epigenetic kit personalised treatment of CD.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting